Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Post by GrandpaTraderon Jan 03, 2021 12:11pm
174 Views
Post# 32211543

Dr. John Fahy

Dr. John Fahy
Dr. John Fahy - good addition to the team. He specializes in the respiratory realm which is what covid/influenza etc falls under. If the study starts showing positive results, his hospital could be one of the first to start implementing with EUA approval and with that peers from other hospitals would follow. Strategically this is a good move.  Side note for those looking for him - He has no Twitter account and you can not find him on LinkedIn. This is a good thing because it will keep people from annoying him and bothering him. Dr.Boulware ended up leaving and not participating from any covid-19 related research after being bombarded and harassed by trolls around the world. 
https://www.ucsfhealth.org/providers/dr-john-fahy
<< Previous
Bullboard Posts
Next >>